Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC

Clinical trial NCT05098990 · UNKNOWN

Trial details

NCT number: NCT05098990
Sponsor: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2021-10-25
Primary completion: 2024-06-15
Enrollment: 328

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.